MPI-451936

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMPI-451936
Drug Alias NameGp41-targeting HIV-CXCR4 fusion inhibitor (Myriad)MPI-451936
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulatorsTransmembrane glycoprotein gp41 inhibitors
TargetsTransmembrane glycoprotein gp41C-X-C motif chemokine receptor 4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMyriad Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMyriad Genetics Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A